{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:33:56Z","timestamp":1790408036064,"version":"4.1.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Technology & Science New-star Training Project","award":["2010B084"],"award-info":[{"award-number":["2010B084"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0158206","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T13:34:16Z","timestamp":1469021656000},"page":"e0158206","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Epilepsy in Adults with Supratentorial Glioblastoma: Incidence and Influence Factors and Prophylaxis in 184 Patients"],"prefix":"10.1371","volume":"11","author":[{"given":"Shuli","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,7,20]]},"reference":[{"issue":"3","key":"ref1","first-page":"333+","article-title":"Epilepsy in glioblastoma patients: basic mechanism and current problems in treatment","volume":"6","author":"J Bruna","year":"2014"},{"key":"ref2","first-page":"492","article-title":"Malignant gliomas in adults","volume":"354","author":"PY Wen","year":"2008"},{"issue":"4","key":"ref3","first-page":"514","article-title":"Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life","volume":"54","author":"M Klein","year":"2003"},{"issue":"6","key":"ref4","first-page":"618","article-title":"Review on Quality of Life Issues in Patients with Primary Brain Tumors","volume":"15","author":"MJB Taphoorn","year":"2010"},{"issue":"7","key":"ref5","first-page":"751","article-title":"Seizure prognosis in brain tumors: new insights and evidence-based management","volume":"19","author":"CJ Vecht","year":"2014"},{"issue":"5","key":"ref6","first-page":"843","article-title":"Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging study","volume":"108","author":"JW Lee","year":"2014"},{"key":"ref7","first-page":"421","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"MSM van Breemen","year":"2007"},{"issue":"12","key":"ref8","first-page":"2186","article-title":"Comparisons of incidence of epilepsy and clinical characters in different grade gliomas","volume":"25","author":"ZJ Yang","year":"2008"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3171\/2009.2.JNS081132","article-title":"Long -term seizure outcome in adult patients undergoing primary resection of malignant brain astrocytomas","volume":"111","author":"KL Chaichana","year":"2009","journal-title":"J Neurosurg"},{"issue":"1","key":"ref10","first-page":"83","article-title":"Epilepsy in the end-of-life phase in patients with high-grade gliomas","volume":"111","author":"A Pace","year":"2013"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3171\/2014.1.JNS131694","article-title":"Evolution of cranial epilepsy surgery complication rates: a 32-year systematic review and meta-analysis","volume":"120","author":"CC Tebo","year":"2014","journal-title":"J Neurosurg"},{"issue":"6","key":"ref12","first-page":"524","article-title":"Surgery for intractable epilepsy","volume":"5","author":"SL Liang","year":"2006"},{"issue":"3","key":"ref13","first-page":"319","article-title":"Epilepsy in glioblastoma multiforme: correlation with glutamine syntretase level","volume":"93","author":"A Rosati","year":"2009"},{"issue":"5","key":"ref14","first-page":"618","article-title":"Glutamine synthetase expression as a waluable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme","volume":"15","author":"A Rosati","year":"2013"},{"issue":"6","key":"ref15","first-page":"822","article-title":"The spectrum of Long-Term Epilepsy-associated Tumors: Long-term Seizure and Tumor Outcome and Neurosurgical Aspects","volume":"44","author":"C Luyken","year":"2003"},{"issue":"4","key":"ref16","first-page":"676","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"AT Berg","year":"2010"},{"issue":"3","key":"ref17","first-page":"291","article-title":"Glioblastoma multiforme: enhancing survival and quality of life","volume":"15","author":"ME Davis","year":"2011"},{"issue":"7","key":"ref18","first-page":"751","article-title":"Expert consensus on appliance of anti-epilepsy drugs after supratentorial craniotomy","volume":"28","year":"2012"},{"key":"ref19","first-page":"564","article-title":"Antiepileptic drug therapy in the perioperative course of neurosurgical patients","volume":"23","author":"M Klimek","year":"2010"},{"issue":"2","key":"ref20","first-page":"211","article-title":"Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumor","volume":"74","author":"V Siomin","year":"2005"},{"key":"ref21","first-page":"CD0044224","article-title":"Antiepileptic drugs for preventing seizure in people wiht brain tumors","author":"IV Tremont-Lukats","year":"2008"},{"key":"ref22","first-page":"1886","article-title":"Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"54","author":"MJ Glantz","year":"2000"},{"issue":"9","key":"ref23","first-page":"665","article-title":"Efficacy and Tolerability of Levetiracetam versus Phenytoin after Supratentorial Neurosurgery","volume":"71","author":"TA Milligan","year":"2008"},{"key":"ref24","first-page":"349","article-title":"Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study","volume":"93","author":"DA Lim","year":"2009"},{"issue":"2","key":"ref25","first-page":"71","article-title":"Should levetiracetam replace phenytoin for seizure prophylaxis after neurosurgery?","volume":"9","author":"NB Fountain","year":"2009"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0158206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T03:54:53Z","timestamp":1540266893000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0158206"}},"subtitle":[],"editor":[{"given":"Peter","family":"Canoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,20]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0158206","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,20]]}}}